Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
01/2014
01/14/2014US8629160 Alkaloid aminoester derivatives and medicinal composition thereof
01/09/2014WO2014005601A1 A process for the preparation of solifenacin or a salt thereof
01/09/2014WO2013142873A3 Complex and structurally diverse compounds
01/08/2014CN103502213A Alkaloid ester and carbamate derivatives and medicinal compositions thereof
01/07/2014CA2694504C (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
01/02/2014US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
01/01/2014CN103492351A Method for producing compound with carbonyl group by using ruthenium carbonyl complex having tridentate ligand as dehydrogenation oxidation catalyst
01/01/2014CN103483334A Crystal form of penehyclidine hydrochloride racemic mixture II and preparation method thereof
01/01/2014CN103483333A Crystal form of penehyclidine hydrochloride racemic mixture I and preparation method thereof
12/2013
12/31/2013US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
12/31/2013US8618131 Biphenyl derivatives
12/27/2013WO2013189920A1 New compound based on cinchona alkaloïds for use in asymmetric michael addition
12/25/2013EP2152670B1 Bridged six-membered ring compounds
12/25/2013CN103467465A Azasetron hydrochloride synthesis method
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/19/2013US20130338186 Amides of acetic and propionic acids
12/19/2013US20130338171 Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
12/18/2013EP2150539B1 Pyridazinone derivatives
12/18/2013CN103450183A Preparation method of succinic acid solifenacin
12/17/2013US8609845 Pyrrolidine inhibitors of IAP
12/17/2013US8609685 SMAC mimetic compounds as apoptosis inducers
12/17/2013US8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases
12/04/2013EP2668186A1 Pharmaceutical composition comprising pyridone derivatives
11/2013
11/28/2013WO2013177024A1 QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
11/28/2013US20130317059 Pharmaceutical composition comprising pyridone derivatives
11/21/2013US20130310366 5-ht3 receptor modulators, methods of making, and use thereof
11/21/2013US20130310357 Azolyl Urea Compounds and Methods of Use Thereof
11/21/2013US20130310353 Novel quinuclidine derivatives and medicinal compositions containing the same
11/20/2013EP2663563A1 Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (r)-mequitazine
11/20/2013CN101913973B Preparation and use of alkylating agents
11/19/2013US8586606 Heterocyclic compounds with affinity to muscarinic receptors
11/12/2013US8580964 Cinchona-based bifucntional organocatalysts and method for preparing chiral hemiesters using the same
11/07/2013US20130296553 Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (r)-mequitazine
11/07/2013US20130296340 Pharmaceutical composition comprising pyridone derivatives
11/05/2013US8575347 Muscarinic acetylcholine receptor antagonists
10/2013
10/24/2013US20130281445 Compounds useful as inhibitors of choline kinase
10/22/2013US8563577 Alkaloid aminoester derivatives and medicinal composition thereof
10/22/2013US8563567 Substituted heterocyclic compounds
10/16/2013CN103351386A Synthetic method of azasetron hydrochloride
10/13/2013CA2812490A1 1,3-oxathiolane derivatives, process for the preparation of 1,3-oxathiolane derivatives and intermediates thereof
10/08/2013US8554373 Preparation and use of alkylating agents
10/08/2013US8551445 Preparation and use of alkylating agents
10/03/2013WO2013147458A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
10/03/2013US20130261114 Compounds useful as inhibitors of choline kinase
10/02/2013EP2643295A1 Glycine derivatives and their use as muscarinic receptor antagonists
09/2013
09/25/2013CN103328477A Pharmaceutical composition comprising pyridone derivatives
09/25/2013CN103012396B Transfer method for isomers of palonosetron hydrochloride
09/24/2013US8541447 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
09/24/2013US8541446 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
09/19/2013WO2013138413A1 Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts
09/18/2013EP2639212A1 Enantioselective organic anhydride reactions
09/18/2013EP2638039A1 Crystalline solifenacin succinate
09/18/2013CN102167698B Difunctional thioamide organic micromolecule catalyst, preparation method thereof and application thereof
09/17/2013CA2740311C Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
09/04/2013CN103275076A S-(+)-3-quinuclidinol preparation method
09/04/2013CN101948468B Preparation method of quinine hydrochloride
09/04/2013CN101633657B Preparation method of palonosetron and palonosetron hydrochloride and injection
09/03/2013US8524736 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
08/2013
08/29/2013US20130225824 Production process of optically active 3-quinuclidinol derivative
08/28/2013EP2630145A1 Carbonate derivatives for the treatment of cough
08/27/2013US8518967 Amides of acetic and propionic acids
08/22/2013WO2013081400A3 Novel benzamide derivative and use thereof
08/22/2013US20130217683 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof
08/22/2013US20130217679 Compositions and Methods for Treatment of Neurodegenerative Disease
08/22/2013US20130217671 Quinoline derivatives and melk inhibitors containing the same
08/20/2013US8513279 Quinuclidine derivatives and medicinal compositions containing the same
08/08/2013US20130203804 Solifenacin salts
08/06/2013CA2560741C Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
08/01/2013US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof
07/2013
07/30/2013CA2561305C Tetrahydro-indazole cannabinoid modulators
07/24/2013CN103221411A A crystalline form of (R)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
07/24/2013CN103221390A Glycine derivatives and their use as muscarinic receptor antagonists
07/23/2013US8492402 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester
07/18/2013US20130184261 Pyridazinone derivatives
07/18/2013US20130184260 Pyridazinone derivatives
07/18/2013US20130183380 Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-yl)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
07/17/2013CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators
07/16/2013US8486937 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof
07/04/2013WO2013098145A1 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
07/04/2013US20130172323 Pyridazinones as gpr119 agonists
07/04/2013US20130172302 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
07/03/2013CN103183670A Synthetic method of palonosetron hydrochloride
07/02/2013US8476441 Intermediates in the enantioselective synthesis of 3-(aminomethyl)-5-methyl-hexanoic acid
07/02/2013US8476296 Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
06/2013
06/26/2013EP2606049A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
06/26/2013CN103172628A (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
06/25/2013US8470786 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
06/19/2013EP2603079A1 Positive allosteric modulators of mglur2
06/19/2013CN103168038A Carbonate derivatives for the treatment of cough
06/13/2013US20130150404 Biphenyl derivatives
06/06/2013WO2013081400A2 Novel benzamide derivative and use thereof
06/06/2013US20130144062 Heteroaryl carboxamides
06/04/2013US8455646 Alkaloid aminoester derivatives and medicinal composition thereof
05/2013
05/28/2013US8450487 Process for the preparation of cis-2-methylspiro (1,3-oxathiolane 5-3′) quinuclidine
05/22/2013CN103113366A Preparation method for 3-quinuclidone
05/16/2013US20130123502 Novel process for the preparation of solifenacin succinate
05/15/2013EP2590973A1 Solifenacin salts
05/15/2013CN101830896B Organic acid salt of optical isomer of penehyclidine
05/14/2013CA2692561C Method for producing solifenacin or salts thereof
05/14/2013CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 58